Beijing Hope Biotechnology Co. Ltd. (GRANDOMICS BIOSCIENCES CO. LTD.)

Company Snapshot

Founded: 2011
Entity Type: Private
Region: China
Headquarter: Wuhan, China
Key Geographics: U.S., U.K., Germany, Austria, Netherlands, Israel, Pakistan, United Arab Emirates, India, Singapore, Malaysia, Australia, New Zealand, Brazil
Corporate Address: 19th Floor, Building C11, Phase II, Software New Town, Huacheng Avenue, East Lake High-tech Zone, Wuhan China Tel. +86-153-8703-7487 www.grandomics.com

Company Overview

GrandOmics Biosciences Co. develops and markets sequencing services to the Chinese market. The company uses PacBio Sequel instruments and is a participant in China’s Precision Medicine Initiative.

GrandOmics and its subsidiary, NextOmics, provide sequencing services through two clinical diagnostics laboratories in China.

NGS-based clinical tests include those for single gene disorders, SMRT sequencing genetic tests, whole exome tests, and carrier screening tests. The company also provides the GrandBox private cloud service to its clinical customers.

GrandOmics operates a facility that houses the following sequencing instruments: 20 Oxford Nanopore GridIon X5 sequencers; one Oxford Nanopore Promethlon sequencer; six Pacific Biosciences Sequel sequencers; and two Bionano Genomics Saphyr genome mapping instruments.

In April 2019, GrandOmics partnered with Oxford Nanopore Technologies on the dbSV100k population genomics structural variation project. The goal of this project is a total of 100,000 genomes by the end of 2021. The project uses Oxford Nanopore’s PromethIon platform to examine genetic variations associated with human health and disease, and develop platforms for clinical diagnostics based on this knowledge.

On the 2020 Nature Index, Grandomics was ranked second in China’s sequencing industry.

Beijing Hope Biotechnology Co. Ltd. (GRANDOMICS BIOSCIENCES CO. LTD.) In Reports

DNA Data Storage: Global Markets and Technologies

BCC Research Market Report for DNA Data Storage technologies reach $1.5 bln by 2027 from $105.5 mln in 2022 at CAGR of 69.8% for the period of 2022 to 2027.

Global DNA Sequencing: Research, Applied and Clinical Markets

BCC Research Market Report for DNA Sequencing Industry. Global market for DNA sequencing technologies and their applications in research, applied and clinical segments.

DNA Data Storage: Global Markets and Technologies

BCC research global markets report for DNA data storage. market trends, with data from 2019, estimates for 2020, and projections of CAGRs through 2025.

Company's Business Segments

  • Third-generation Sequencing Platform : This segment includes Scientific and Technological Services, Medical Diagnosis Services, Bioinformatics Services, Advanced Manufacturing Services.

Applications/End User Industries

  • Proteomics
  • Basic Scientific Research
  • Animal And Plant Genomics Research
  • Transcriptomics Research
  • Genetic Disease Diagnosis
  • Microbiome
  • Tumor Diagnosis
  • Pathogenic Microorganism Diagnosis
  • Single-Cell Full-Length Transcriptome
  • Nanopore Respiratory Multiple Pathogen Diagnosis
  • Medical Diagnosis
  • Biotechnology
  • Bioinformatics
  • Life Sciences
AI Sentiment